{"id":150964,"date":"2024-10-10T04:01:04","date_gmt":"2024-10-10T04:01:04","guid":{"rendered":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/10\/10\/pharma-giant-gsk-to-pay-2-2-to-settle-zantac-lawsuits\/"},"modified":"2024-10-10T04:01:04","modified_gmt":"2024-10-10T04:01:04","slug":"pharma-giant-gsk-to-pay-2-2-to-settle-zantac-lawsuits","status":"publish","type":"post","link":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/10\/10\/pharma-giant-gsk-to-pay-2-2-to-settle-zantac-lawsuits\/","title":{"rendered":"Pharma giant GSK to pay $2.2 to settle Zantac lawsuits"},"content":{"rendered":"
\"Pharma<\/div>


\n<\/p>\n

\n

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (\u00a31.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.<\/p>\n

The firm announced that it has reached agreements with 10 law firms who represent around 80,000 claimants. The settlements account for 93% of all cases.<\/p>\n

GSK will also pay $70m to resolve a whistleblower complaint by a laboratory that alleged the drugmaker defrauded the US government by concealing Zantac’s cancer risks.<\/p>\n

GSK did not admit wrongdoing in any of the cases.<\/p>\n<\/div>\n

\n

The company said in a statement to investors<\/a> that the settlements “remove significant financial uncertainty, risk and distraction associated with protracted litigation.”<\/p>\n

Zantac was first approved for sale in the US in 1983.<\/p>\n

Within five years it was the world’s best-selling drug, with annual sales topping $1bn.<\/p>\n

In 2020, US regulators pulled Zantac off shelves due to fears that a key ingredient, ranitidine, could turn into a substance that may cause cancer when exposed to heat. <\/p>\n

That move led to tens of thousands of lawsuits against the drug’s manufacturers.<\/p>\n

The previous year, UK doctors were told to stop prescribing four types of Zantac<\/a> as a “precautionary measure”.<\/p>\n

It followed concerns in several countries that the products may contain an impurity that has been linked to cancer.<\/p>\n

As well as being sold by GSK, the drug has also been marketed by other major pharmaceutical firms Pfizer, Sanofi and Boehringer Ingelheim.<\/p>\n

Pfizer and Sanofi have both agreed to settle cases. <\/p>\n

Boehringer Ingelheim is the exception. It has not announced any major settlements.<\/p>\n

A drug under the name of Zantac 360, which contains no ranidine, is still being currently sold.<\/p>\n<\/div>\n


\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (\u00a31.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer. The firm announced that it has reached agreements with 10 law firms who represent around 80,000 claimants. The settlements account for […]<\/p>\n","protected":false},"author":2,"featured_media":150965,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"tdm_status":"","tdm_grid_status":"","fifu_image_url":"https:\/\/ichef.bbci.co.uk\/news\/1024\/branded_news\/df52\/live\/5e028570-86b9-11ef-ab36-e92167c99352.jpg","fifu_image_alt":"","footnotes":""},"categories":[604],"tags":[596,73217,58794,795,20585,3291,24350],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/150964"}],"collection":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/comments?post=150964"}],"version-history":[{"count":1,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/150964\/revisions"}],"predecessor-version":[{"id":150966,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/posts\/150964\/revisions\/150966"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media\/150965"}],"wp:attachment":[{"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/media?parent=150964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/categories?post=150964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news.talkwithrattan.com\/index.php\/wp-json\/wp\/v2\/tags?post=150964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}